.Pharmacolibrary.Drugs.ATC.J.J01DE03 .Pharmacolibrary.Drugs.ATC.J.J01DE03| name: | Cefozopran |
| ATC code: | J01DE03 | route: | intravenous |
| n-compartments | 2 |
Cefozopran is a fourth-generation cephalosporin antibiotic used primarily in Japan for the treatment of a broad spectrum of bacterial infections, including respiratory tract, urinary tract, skin, and intra-abdominal infections. It is administered mainly in hospital settings and is not currently approved in the US or EU.
Healthy adult subjects after single intravenous administration.
Wu, GL, et al., & Wu, LH (2015). Pharmacokinetics of cefozopran by single and multiple intravenous infusions in healthy Chinese volunteers. Drugs in R&D 15(1) 63–70. DOI:10.1007/s40268-014-0075-3 PUBMED:https://pubmed.ncbi.nlm.nih.gov/25644122
Nomura, K, et al., & Taniwaki, M (2008). Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis. The Journal of antimicrobial chemotherapy 61(4) 892–900. DOI:10.1093/jac/dkn038 PUBMED:https://pubmed.ncbi.nlm.nih.gov/18276604
Ikawa, K, et al., & Kobayashi, R (2009). Population pharmacokinetic modeling and pharmacodynamic assessment of cefozopran in pediatric patients. The Japanese journal of antibiotics 62(5) 435–444. PUBMED:https://pubmed.ncbi.nlm.nih.gov/20055120